NSC |
Compound |
Enrichment |
Correlation |
NSC 744025 |
diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate |
0.000613655894404025 |
0.36958721 |
NSC 749379 |
Null |
0.000613655894404025 |
0.57559357 |
NSC 617823 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.000706163530262832 |
0.75770307 |
NSC 639981 |
Null |
0.000706163530262832 |
0.65001018 |
NSC 657822 |
(1R)-3,3-Dibromocamphor |
0.000706163530262832 |
0.55974344 |
NSC 659936 |
Null |
0.000706163530262832 |
0.68606261 |
NSC 661415 |
2-Chloro-3-(2-butoxyethoxy)naphthazarin |
0.000706163530262832 |
0.75046453 |
NSC 662784 |
Null |
0.000706163530262832 |
0.72610641 |
NSC 674312 |
Pyrazolo[1,5-a]pyrimidin-2-amine, 5,7-bis(dibromomethyl)-3-nitro- |
0.000706163530262832 |
0.74630645 |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.000706163530262832 |
0.62710453 |